RAS oncogenes: the first 30 years.

Nat Rev Cancer 2003 06;3(6):459-65

Molecular Oncology Programme, Centro Nacional de Investigaciones Oncológicas, Melchor Fernández Almagro 3, 28029 Madrid, Spain.

From the pioneering work with acute transforming retroviruses to the current post-genomic era, RAS genes have always been at the leading edge of signal transduction and molecular oncology. Yet, a complete understanding of RAS function and dysfunction - mainly in human cancer - is still to come. The knowledge that has accumulated since their discovery 30 years ago has, however, been remarkable, and should pave the way for not only solving the outstanding issues regarding RAS biology, but also for developing efficacious drugs that could have a significant impact on cancer treatment.

Download full-text PDF

Source
http://www.nature.com/articles/nrc1097
Publisher Site
http://dx.doi.org/10.1038/nrc1097DOI Listing
June 2003
1 Read

Publication Analysis

Top Keywords

solving outstanding
4
oncology complete
4
complete understanding
4
understanding ras
4
ras
4
molecular oncology
4
outstanding issues
4
ras biology
4
signal transduction
4
issues ras
4
transduction molecular
4
ras function
4
function dysfunction
4
accumulated discovery
4
discovery years
4
ago remarkable
4
years ago
4
knowledge accumulated
4
remarkable pave
4
pave solving
4

References

(Supplied by CrossRef)

JJ Harvey et al.
Nature 1964

WH Kirsten et al.
J. Natl Cancer Inst. 1967

RL Peters et al.
J. Natl Cancer Inst. 1974

S Rasheed et al.
Proc. Natl Acad. Sci. USA 1978

EM Scolnick et al.
J. Virol. 1973

GL Hager et al.
J. Virol. 1979

N Tsuchida et al.
J. Virol. 1981

RW Ellis et al.
Nature 1981

M Wigler et al.
Cell 1978

C Shih et al.
Proc. Natl Acad. Sci. USA 1979

C Shih et al.
Nature 1981

Similar Publications